Predictors of pulmonary exacerbation treatment in cystic fibrosis

BACKGROUND: Most studies of pulmonary exacerbations (PEx) in cystic fibrosis (CF) focus on intravenous (IV)-treated PEx, though most PEx are treated with oral antibiotics. Our objectives were to describe predictors of antibiotic choice and outcomes for PEx initially identified in clinic. METHODS: Fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cyst Fibros
Hauptverfasser: Sanders, Don B., Ostrenga, Joshua S., Rosenfeld, Margaret, Fink, Aliza K., Schechter, Michael S., Sawicki, Gregory S., Flume, Patrick A., Morgan, Wayne J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940539/
https://ncbi.nlm.nih.gov/pubmed/31257102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2019.06.008
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge